Clinical use of the activated partial thromboplastin time and prothrombin time for screening: A review of the literature and current guidelines for testing

Clinics in Laboratory Medicine

Volumn 34, Issue 3, 2014, Pages 453-477

  Levy, Jerrold H ^a   Szlam, Fania ^b   Wolberg, Alisa S ^c   Winkler, Anne ^b  

^a DUKE UNIVERSITY HOSPITAL   (United States)

^b EMORY UNIVERSITY HOSPITAL   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Activated clotting time; Activated partial thromboplastin time; Anticoagulation; Monitoring; Prothrombin time; Surgery

Indexed keywords

DAPTOMYCIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN; ANTICOAGULANT AGENT;

ACTIVATED CLOTTING TIME; ALPHA 2 ANTIPLASMIN DEFICIENCY; ANTICOAGULANT THERAPY; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING FACTOR 11 DEFICIENCY; BLOOD CLOTTING FACTOR 12 DEFICIENCY; BLOOD CLOTTING FACTOR 13 DEFICIENCY; BLOOD CLOTTING FACTOR 7 DEFICIENCY; BLOOD CLOTTING PARAMETERS; BLOOD CLOTTING TEST; BODY TEMPERATURE; CARDIOPULMONARY BYPASS; CLINICAL DECISION MAKING; CLINICAL PRACTICE; DIAGNOSTIC VALUE; DIET; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; GAUCHER DISEASE; HEMOPHILIA A; HEMOPHILIA B; HEMOSTASIS; HIGH MOLECULAR WEIGHT KININOGEN DEFICIENCY; HUMAN; HYPERTHERMIA; HYPOTHERMIA; INTERNATIONAL NORMALIZED RATIO; KASABACH MERRITT SYNDROME; LUPUS LIKE SYNDROME; MEDICAL HISTORY; MONITORING; NEUROFIBROMATOSIS; NOONAN SYNDROME; PARTIAL THROMBOPLASTIN TIME; PASSOVOY FACTOR DEFICIENCY; PERIOPERATIVE BLEEDING; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PREDICTIVE VALUE; PREKALLIKREIN DEFICIENCY; PRIORITY JOURNAL; PROTHROMBIN DEFICIENCY; PROTHROMBIN TIME; REVIEW; ROOM TEMPERATURE; SCREENING; SICKLE CELL ANEMIA; THROMBOELASTOGRAPHY; TIME; VON WILLEBRAND DISEASE; BLOOD LOSS, SURGICAL; CHEMICALLY INDUCED; DRUG MONITORING; EVIDENCE BASED MEDICINE; ORAL DRUG ADMINISTRATION; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; PROCEDURES; STANDARDS;

ADMINISTRATION, ORAL; ANTICOAGULANTS; BLOOD LOSS, SURGICAL; DRUG MONITORING; EVIDENCE-BASED MEDICINE; HUMANS; PARTIAL THROMBOPLASTIN TIME; PERIOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINES AS TOPIC; PROTHROMBIN TIME;

EID: 84906937837     PISSN: 02722712     EISSN: 15579832     Source Type: Journal    
DOI: 10.1016/j.cll.2014.06.005     Document Type: Review

References (89)

1. Halbmayer W.M., Haushofer A., Schon R., et al. The prevalence of moderate and severe FXII (Hageman factor) deficiency among the normal population: evaluation of the incidence of FXII deficiency among 300 healthy blood donors. Thromb Haemost 1994, 71(1):68-72.
2. Munro J., Booth A., Nicholl J. Routine preoperative testing: a systematic review of the evidence. Health Technol Assess 1997, 1(12):i-iv. 1-62.
3. Reeves B.C., Ascione R., Chamberlain M.H., et al. Effect of body mass index on early outcomes in patients undergoing coronary artery bypass surgery. JAm Coll Cardiol 2003, 42(4):668-676.
4. Chee Y.L., Crawford J.C., Watson H.G., et al. Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures. British Committee for Standards in Haematology. Br J Haematol 2008, 140(5):496-504.
5. Shetty S., Ghosh K., Mohanty D. Comparison of four commercially available activated partial thromboplastin time reagents using a semi-automated coagulometer. Blood Coagul Fibrinolysis 2003, 14(5):493-497.
6. Clinical and Laboratory Standards Institute Defining, establishing, and verifyingreference intervals in the clinical laboratory; approved guideline 2008, CLSI document C28-A3, Clinical and Laboratory Standards Institute, Wayne (PA). 3rd edition.
7. Schouwers S.M., Delanghe J.R., Devreese K.M. Lupus Anticoagulant (LAC) testing in patients with inflammatory status: does C-reactive protein interfere with LAC test results?. Thromb Res 2010, 125(1):102-104.
8. World Health Organization (WHO). WHO Expert Committee on Biological Standardization - Thirty-Third report. Annex 3, WHO Technical Report Series, no. 687 - Requirements for thromboplastins and plasma used to control oral anticoagulant therapy (Requirements for Biological Substances no. 30, revised 1982). 1983. Available at: Accessed December 5, 2013. http://onlinelibrary.wiley.com/doi/10.1111/j.1538-7836.2004.00775.x/pdf.
9. Sosothikul D., Seksarn P., Lusher J.M. Pediatric reference values for molecular markers in hemostasis. JPediatr Hematol Oncol 2007, 29(1):19-22.
10. Preoperative routines. The Swedish Council on Technology Assessment in Health Care. Int J Technol Assess Health Care 1991, 7(1):95-100.
11. Peterson P., Hayes T.E., Arkin C.F., et al. The preoperative bleeding time test lacks clinical benefit: College of American Pathologists' and American Society of Clinical Pathologists' position article. Arch Surg 1998, 133(2):134-139.
12. Chee Y.L., Greaves M. Role of coagulation testing in predicting bleeding risk. Hematol J 2003, 4(6):373-378.
13. Eckman M.H., Erban J.K., Singh S.K., et al. Screening for the risk for bleeding or thrombosis. Ann Intern Med 2003, 138(3):W15-W24.
14. Dzik W.H. Predicting hemorrhage using preoperative coagulation screening assays. Curr Hematol Rep 2004, 3(5):324-330.
15. Sié P., Steib A. Central laboratory and point of care assessment of perioperative hemostasis. Can J Anaesth 2006, 53(Suppl 6):S12-S20.
16. Kozek-Langenecker S.A. Perioperative coagulation monitoring. Best Pract Res Clin Anaesthesiol 2010, 24(1):27-40.
17. Klopfenstein C.E. Preoperative clinical assessment of hemostatic function inpatients scheduled for a cardiac operation. Ann Thorac Surg 1996, 62(6):1918-1920.
18. Krishna P., Lee D. Post-tonsillectomy bleeding: a meta-analysis. Laryngoscope 2001, 111(8):1358-1361.
19. Eisenberg J.M., Clarke J.R., Sussman S.A. Prothrombin and partial thromboplastin times as preoperative screening tests. Arch Surg 1982, 117(1):48-51.
20. Borzotta A.P., Keeling M.M. Value of the preoperative history as an indicator of hemostatic disorders. Ann Surg 1984, 200(5):648-652.
21. Rohrer M.J., Michelotti M.C., Nahrwold D.L. Aprospective evaluation of the efficacy of preoperative coagulation testing. Ann Surg 1988, 208(5):554-557.
22. Macpherson C.R., Jacobs P., Dent D.M. Abnormal peri-operative haemorrhage in asymptomatic patients is not predicted by laboratory testing. SAfr Med J 1993, 83(2):106-108.
23. Houry S., Georgeac C., Hay J.M., et al. Aprospective multicenter evaluation of preoperative hemostatic screening tests. The French Associations for Surgical Research. Am J Surg 1995, 170(1):19-23.
24. Koscielny J., Ziemer S., Radtke H., et al. Apractical concept for preoperative identification of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 2004, 10(3):195-204.
25. Murray D., Pennell B., Olson J. Variability of prothrombin time and activated partial thromboplastin time in the diagnosis of increased surgical bleeding. Transfusion 1999, 39(1):56-62.
26. Colon-Otero G., Gilchrist G.S., Holcomb G.R., et al. Preoperative evaluation of hemostasis in patients with congenital heart disease. Mayo Clin Proc 1987, 62(5):379-385.
27. Ferraris V.A., Gildengorin V. Predictors of excessive blood use after coronary artery bypass grafting. A multivariate analysis. JThorac Cardiovasc Surg 1989, 98(4):492-497.
28. Gravlee G.P., Arora S., Lavender S.W., et al. Predictive value of blood clotting tests in cardiac surgical patients. Ann Thorac Surg 1994, 58(1):216-221.
29. Williams G.D., Bratton S.L., Riley E.C., et al. Coagulation tests during cardiopulmonary bypass correlate with blood loss in children undergoing cardiac surgery. JCardiothorac Vasc Anesth 1999, 13(4):398-404.
30. Aghajanian A., Grimes D.A. Routine prothrombin time determination before elective gynecologic operations. Obstet Gynecol 1991, 78(5 Pt 1):837-839.
31. Bolger W.E., Parsons D.S., Potempa L. Preoperative hemostatic assessment of the adenotonsillectomy patient. Otolaryngol Head Neck Surg 1990, 103(3):396-405.
32. Burk C.D., Miller L., Handler S.D., et al. Preoperative history and coagulation screening in children undergoing tonsillectomy. Pediatrics 1992, 89(4 Pt 2):691-695.
33. Close H.L., Kryzer T.C., Nowlin J.H., et al. Hemostatic assessment of patients before tonsillectomy: a prospective study. Otolaryngol Head Neck Surg 1994, 111(6):733-738.
34. Kang J., Brodsky L., Danziger I., et al. Coagulation profile as a predictor for post-tonsillectomy and adenoidectomy (T+ A) hemorrhage. Int J Pediatr Otorhinolaryngol 1994, 28(2-3):157-165.
35. Zagólski O. Post-tonsillectomy haemorrhage-do coagulation tests and coagulopathy history have predictive value?. Acta Otorrinolaringol Esp 2010, 61(4):287-292. [in Spanish].
36. Suchman A.L., Mushlin A.I. How well does the activated partial thromboplastin time predict postoperative hemorrhage?. JAMA 1986, 256(6):750-753.
37. Gewirtz A.S., Miller M.L., Keys T.F. The clinical usefulness of the preoperative bleeding time. Arch Pathol Lab Med 1996, 120(4):353-356.
38. Reddy N.M., Hall S.W., MacKintosh F.R. Partial thromboplastin time: prediction of adverse events and poor prognosis by low abnormal values. Arch Intern Med 1999, 159(22):2706-2710.
39. Ng K.F., Lai K.W., Tsang S.F. Value of preoperative coagulation tests: reappraisal of major noncardiac surgery. World J Surg 2002, 26(5):515-520.
40. Wojtkowski T.A., Rutledge J.C., Matthews D.C. The clinical impact of increased sensitivity PT and APTT coagulation assays. Am J Clin Pathol 1999, 112(2):225-232.
41. Genecov D.G., Por Y.C., Barcelo C.R., et al. Preoperative screening for coagulopathy using prothrombin time and partial thromboplastin time in patients requiring primary cranial vault remodeling. Plast Reconstr Surg 2005, 116(2):389-394.
42. De Saint Blanquat L., Simon L., Laplace C., et al. Preoperative coagulation tests in former preterm infants undergoing spinal anaesthesia. Paediatr Anaesth 2002, 12(4):304-307.
43. Horlocker T.T., Nuttall G.A., Dekutoski M.B., et al. The accuracy of coagulation tests during spinal fusion and instrumentation. Anesth Analg 2001, 93(1):33-38.
44. Schramm B., Leslie K., Myles P.S., et al. Coagulation studies in preoperative neurosurgical patients. Anaesth Intensive Care 2001, 29(4):388-392.
45. Howells R.C., Wax M.K., Ramadan H.H. Value of preoperative prothrombin time/partial thromboplastin time as a predictor of postoperative hemorrhage in pediatric patients undergoing tonsillectomy. Otolaryngol Head Neck Surg 1997, 117(6):628-632.
46. Manning S.C., Beste D., McBride T., et al. An assessment of preoperative coagulation screening for tonsillectomy and adenoidectomy. Int J Pediatr Otorhinolaryngol 1987, 13(3):237-244.
47. Zwack G.C., Derkay C.S. The utility of preoperative hemostatic assessment in adenotonsillectomy. Int J Pediatr Otorhinolaryngol 1997, 39(1):67-76.
48. Asaf T., Reuveni H., Yermiahu T., et al. The need for routine pre-operative coagulation screening tests (prothrombin time PT/partial thromboplastin time PTT) for healthy children undergoing elective tonsillectomy and/or adenoidectomy. Int J Pediatr Otorhinolaryngol 2001, 61(3):217-222.
49. Jonnavithula N., Durga P., Pochiraju R., et al. Routine preoperative coagulation screening detects a rare bleeding disorder. Anesth Analg 2009, 108(1):76-78.
50. Hattersley P.G. The activated coagulation time of whole blood as a routine pre-operative sceening test. Calif Med 1971, 114(5):15-18.
51. Wieland A., Belden L., Cunningham M. Preoperative coagulation screening for adenotonsillectomy: a review and comparison of current physician practices. Otolaryngol Head Neck Surg 2009, 140(4):542-547.
52. American Academy of Otolaryngology - Head and Neck Surgery. Clinical Indicators Compendium. 2009. Available at: Accessed December 12, 2013. http://https://www.entnet.org/content/clinical-indicato.
53. Baker R. Pre-operative hemostatic assessment and management. Transfus Apher Sci 2002, 27(1):45-53.
54. Reeves B. Clinical guideline 3. Preoperative tests. The use of routine preoperative tests for elective surgery: London: National Institute for Clinical Excellence; Available at: Accessed December 12, 2013. http://guidance.nice.org.uk/CG3/Guidance/pdf/English.
55. Kamal A.H., Tefferi A., Pruthi R.K. How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults. Mayo Clin Proc 2007, 82(7):864-873.
56. Levy J.H., Dutton R.P., Hemphill J.C., et al. Multidisciplinary approach to the challenge of hemostasis. Anesth Analg 2010, 110(2):354-364.
57. De Hert S., Imberger G., Carlisle J., et al. Preoperative evaluation of the adult patient undergoing non-cardiac surgery: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2011, 28(10):684-722.
58. Webster P.S., Oleson F.B., Paterson D.L., et al. Interaction of daptomycin with two recombinant thromboplastin reagents leads to falsely prolonged patient prothrombin time/International Normalized Ratio results. Blood Coagul Fibrinolysis 2008, 19(1):32-38.
59. Briselli M.F., Ellman L. Kaolin-correctable prolongation of the activated partial thromboplastin time. Am J Clin Pathol 1980, 74(5):677-680.
60. Milos M., Herak D.C., Zadro R. Discrepancies between APTT results determined with different evaluation modes on automated coagulation analyzers. Int J Lab Hematol 2010, 32(1 Pt 2):33-39.
61. Adcock D., Kressin D., Marlar R.A. The effect of time and temperature variables on routine coagulation tests. Blood Coagul Fibrinolysis 1998, 9(6):463-470.
62. Salvagno G.L., Lippi G., Montagnana M., et al. Influence of temperature and time before centrifugation of specimens for routine coagulation testing. Int J Lab Hematol 2009, 31(4):462-467.
63. Rao L.V., Okorodudu A.O., Petersen J.R., et al. Stability of prothrombin time and activated partial thromboplastin time tests under different storage conditions. Clin Chim Acta 2000, 300(1-2):13-21.
64. Leeming D.R., Craig S., Stevenson K.J., et al. The determination of INR in stored whole blood. JClin Pathol 1998, 51(5):360-363.
65. Froom P., Abramova D., Bar-El M., et al. Reliability of delayed prothrombin time INR determinations in a central laboratory using off-site blood sampling. Clin Lab Haematol 2001, 23(3):189-192.
66. Felfernig M., Blaicher A., Kettner S.C., et al. Effects of temperature on partial thromboplastin time in heparinized plasma invitro. Eur J Anaesthesiol 2001, 18(7):467-470.
67. Boldt L.H., Fraszl W., Rocker L., et al. Changes in the haemostatic system after thermoneutral and hyperthermic water immersion. Eur J Appl Physiol 2008, 102(5):547-554.
68. Cavallini M., Baruffaldi Preis F.W., Casati A. Effects of mild hypothermia on blood coagulation in patients undergoing elective plastic surgery. Plast Reconstr Surg 2005, 116(1):316-321. [discussion: 322-3].
69. Moriwaki Y., Sugiyama M. Effect of fasting on coagulation factors in patients who undergo major abdominal surgery. Am Surg 2010, 76(2):168-171.
70. Conaglen P.J., Akowuah E., Theodore S., et al. Implications for cardiac surgery in patients with factor XII deficiency. Ann Thorac Surg 2010, 89(2):625-626.
71. Favaloro E.J., Zafer M., Nair S.C., et al. Evaluation of primary haemostasis in people with neurofibromatosis type 1. Clin Lab Haematol 2004, 26(5):341-345.
72. Massarano A.A., Wood A., Tait R.C., et al. Noonan syndrome: coagulation and clinical aspects. Acta Paediatr 1996, 85(10):1181-1185.
73. Lapecorella M., Mariani G. Factor VII deficiency: defining the clinical picture and optimizing therapeutic options. Haemophilia 2008, 14(6):1170-1175.
74. Meeks S.L., Abshire T.C. Abnormalities of prothrombin: a review of the pathophysiology, diagnosis, and treatment. Haemophilia 2008, 14(6):1159-1163.
75. Seligsohn U. Factor XI deficiency in humans. JThromb Haemost 2009, 7(Suppl 1):84-87.
76. Raffini L.J., Niebanck A.E., Hrusovsky J., et al. Prolongation of the prothrombin time and activated partial thromboplastin time in children with sickle cell disease. Pediatr Blood Cancer 2006, 47(5):589-593.
77. Borud L.J., Matarasso A., Spaccavento C.M., et al. Factor XI deficiency: implications for management of patients undergoing aesthetic surgery. Plast Reconstr Surg 1999, 104(6):1907-1913.
78. Katz K., Tamary H., Lahav J., et al. Increased operative bleeding during orthopaedic surgery in patients with type I Gaucher disease and bone involvement. Bull Hosp Jt Dis 1999, 58(4):188-190.
79. Menendez L.R., Thommen V.D. Kasabach-Merritt syndrome complicating treatment of a closed femoral fracture. Clin Orthop Relat Res 1995, (316):185-188.
80. Jackson J.M., Marshall L.R., Herrmann R.P. Passovoy factor deficiency in five Western Australian kindreds. Pathology 1981, 13(3):517-524.
81. Jeske A.H., Suchko G.D. Lack of a scientific basis for routine discontinuation of oral anticoagulation therapy before dental treatment. JAm Dent Assoc 2003, 134(11):1492-1497.
82. Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators. Circulation 1994, 90(4):1631-1637.
83. Douketis J.D., Spyropoulos A.C., Spencer F.A., et al. Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012, 141(Suppl 2):e326S-e350S.
84. Garcia D.A., Baglin T.P., Weitz J.I., et al. Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012, 141(Suppl 2):e24S-e43S.
85. Kearon C., Akl E.A., Comerota A.J., et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012, 141(Suppl 2):e419S-e494S.
86. Despotis G.J., Levine V., Goodnough L.T. Relationship between leukocyte count and patient risk for excessive blood loss after cardiac surgery. Crit Care Med 1997, 25(8):1338-1346.
87. Puetz J. Fresh frozen plasma: the most commonly prescribed hemostatic agent. JThromb Haemost 2013, 11(10):1794-1799.
88. Rosendaal F.R., Reitsma P.H. Is administering blood as useless as blood letting?. JThromb Haemost 2013, 11(10):1793.
89. Mannucci P.M., Canciani M.T., Mari D., et al. The varied sensitivity of partial thromboplastin and prothrombin time reagents in the demonstration of the lupus-like anticoagulant. Scand J Haematol 1979, 22(5):423-432.